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Abstract
Background: Smoking is one of the leading causes of millions of deaths worldwide. During cigarette smoking,
most affected and highly exposed cells are the alveolar epithelium and generated oxidative stress in these cells
leads to death and damage. Several studies suggested that oxidative stress causes membrane remodeling via
Phospholipase A2s but in the case of cigarette smokers, mechanistically study is not yet fully defined. In view of
present perspective, we evaluated the involvement of cytosolic phospholipase A2 (cPLA2) IVA as therapeutic target
in cigarette smoke induced pathologies in transformed type I and type II alveolar epithelial cells.
Methods: Transformed type I (WI26) and type II (A549) alveolar epithelial cells were used for the present study.
Cigarette smoke condensate (CSC) was prepared from most commonly used cigarette (Gold Flake with filter) by the
Indian population. CSC-induced molecular changes were evaluated through cell viability using MTT assay, reactive
oxygen species (ROS) measurement using 2,7 dichlorodihydrofluorescin diacetate (DCFH-DA), cell membrane
integrity using fluorescein diacetate (FDA) and ethidium bromide (EtBr) staining, super oxide dismutase (SOD) levels,
cPLA2 activity and molecular involvement of specific cPLA2s at selected 24 h time period.
Results: CSC-induced response on both type of epithelial cells shown significantly reduction in cell viability,
declined membrane integrity, with differential escalation of ROS levels in the range of 1.5–15 folds and pointedly
increased cPLA2 activity (p < 0.05). Likewise, we observed distinction antioxidant potential in these two types of
lineages as type I cells had considerably higher SOD levels when compared to type II cells (p < 0.05). Further
molecular expression of all cPLA2s increased significantly in a dose dependent manner, specifically cytosolic
phospholipase A2 IVA with maximum manifestation of 3.8 folds. Interestingly, CSC-induced ROS levels and cPLA2s
expression were relatively higher in A549 cells as compared to WI26 cells.
Conclusions: The present study indicates that among all cPLA2s, specific cPLA2 IVA are the main enzymes involved
in cigarette smoke induced anomalies in type I and type II lung epithelial cells and targeting them holds
tremendous possibilities in cigarette smoke induced lung pathologies.
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Background
Cigarette smoking is leading cause of deaths and pro-
jected to cause 8–10 million deaths per year worldwide
[1]. It is associated with different types of lung cancer
and approximately one third of all cancer death [1–3].
Currently more than 370 billion cigarettes are being
consumed by smokers globally and it has been projected
that more than 30 % of the people will be smokers by
2030 [2]. On the other hand it has been expected that
rate of smoking will be reached 70 % in developing
countries [1]. It has been documented that single puff of
cigarette smoke contains 1017 oxidant molecules out of
which 1015 are reactive oxygen species/ reactive nitrogen
species. Moreover, these ROS/RNS are known to be one
of the causative factors in various lung pathologies
including cancer and chronic obstructive pulmonary
disease (COPD) [4–6]. During cigarette smoking, the
most affected and highly exposed cells are the alveolar
epithelium which is lined by type-I (~90–95 %) and
type-II (~5–10 %) epithelial cells. In addition, damage
and death of epithelial cells induced by cigarette smoke
exposure can mostly be accounted for by an increased in
oxidant stress. Enhanced levels of free radicals/oxidants
leads to oxidative stress and initation of repair processes
whether started as part of an inflammatory response or
as a response to injury is still not clear in cigarette
smokers. In this context, one of the hallmark enzymes
are Phospholipase A2s which are responsible for mem-
branes remodeling [7–9] but in the case of cigarette
smokers mechanistically study is not yet fully defined.
PLA2s are lipolytic enzymes that catalyze the hy-
drolysis of acyl-groups at the sn-2 position of glycero-
phospholipids and produce free fatty acids and lyso-
Phospholipids by an interfacial activation catalytic
mechanism. To date, at least 26 genes that encode vari-
ous types of PLA2 proteins with esterase’s activity have
been identified in human and are assigned to five dif-
ferent groups. (i) Secretory PLA2s with molecular
weight of 14 kDa, (ii) the 85 kDa cytosolic PLA2s, (iii)
Ca2+ independent PLA2s (iv) Platelet-activating factor
acetyl hydrolase and (v) lysosomal PLA2s. These PLA2s
were differentiated on the basis of their sequence,
molecular weight, disulfide bonding patterns, require-
ment for Ca2+ to their biochemical characteristics and
localization [10–13]. It has been suggested that PLA2
isoforms are involved either in the promotion or in the
resolution of inflammation depending upon cell type
and generation of eicosanoid [14–16]. In this context
cytosolic phospholipase A2s (cPLA2s) are the main en-
zymes mediating arachidonic acid release and pro-
inflammatory eicosanoids production. Moreover these bio-
molecules are associated with chronic inflammation which
is a recognized risk factor for carcinogenesis [17–19]. The
overall aim of this study was to investigate the involvement
of particular cPLA2 which could be proposed as future
therapeutic target during cigarette smoke induced patholo-




WI26 (type-I) lung epithelial cell line was procured
from American type culture collection (ATCC), Rock-
ville, MD (USA), (ATCC® CCL-95.1™, https://www.atc
c.org/Products/All/CCL-95.1.aspx). A549 (type-II) lung
epithelial cell line was procured from National centre for
cell science (NCCS), pune, India (http://www.nccs.res.in/
CR5.html). PLA2-inhibitors bromoenol lactone (BEL),
arachidonyl trifluroethyl ketone (ATK), bromophenacyl
bromide (BPB), DCFH-DA, FDA and other general re-
agents were purchased from Sigma (St. Louis, MO, U.S.A.).




Human lung epithelial type I (WI26) and type II (A549)
cells were maintained in continuous culture at 37 °C
temperature and 5 % CO2 in RPMI-1640 medium with
10 % fetal bovine serum (FBS). After every 48 h, depleted
medium from the culture flask was replaced with fresh
medium. Experimental design is represented as sche-
matic view (Additional file 1: Figure S1).
Cigarette smoke condensate preparation
Cigarette smoke condensate was prepared in our own
laboratory according to standardized method of Kaushik
2009 [20], from most commonly used cigarettes (Gold
Flake with filter) by the Indian population [21]. In brief
smoke from a burning cigarette was sucked into a flask
containing acetone with the help of a vacuum pump.
Three ways connecting glass joint was used for suction.
The rate of airflow was regulated by a valve so that
cigarette burns upto bud in approximately 6 min. Acet-
one was evaporated under vacuum/nitrogen gas and the
residue i.e. CSC was used for the experiments. CSC was
dissolved in DMSO, in such a way that the final concen-
tration of DMSO in plates did not exceed 0.025 % in
culture medium. Further, dilution of CSC stocks was
done with sterile PBS.
Cell viability assay
Effect of CSC on cell viability was evaluated by the 3-
(4,5- dimethylthiazol-2-yl)-diphenyltetrazolium brom-
ide (MTT) dye uptake method [22]. Briefly, 2 x 103cells
were seeded in 96-well plates and allowed to grow over-
night. After 24 h of priming, cells were treated with differ-
ent concentrations of CSC for 24 h. Before treatment;
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medium was replaced with fresh medium. Four h before
the end of desired time interval, 20 μl of MTT solution
(2.5 mg/ml) was added to each well. After 4 h, resulting
formazan crystals were dissolved in 40 μl of lysis buffer.
The developed color was read at 540 nm on ELISA reader.
The relative viability was calculated as described earlier.
Reactive oxygen species
Levels of intracellular ROS were measured by the shift in
fluorescent intensity resulting from oxidation of DCFH-
DA fluorescence dye by the method of Wan et al. [23]. In
brief, cells (0.5 x 105 cells/well) were seeded into 12 well
culture plates and allowed to grow overnight. Cells were
challenged with CSC for 24 h. Before completion of treat-
ment, cells were incubated with 5 μM DCFH-DA fluores-
cence dye for 30 min. After completion of treatment, cells
were washed, harvested and re-suspended in ice-chilled
PBS and analyzed by flow cytometery (FACScan) and shift
in fluorescent peak was represented in terms of mean
fluorescent intensity (MFI).
Cellular integrity by FDA uptake
Cellular injury was determined by the FDA and ethidium
bromide staining method [24]. FDA is an indicator of
membrane integrity and cytoplasmic esterase activity. So
the cells with intact membranes fluoresce green and cells
with damaged membranes fluoresce red. Cells after CSC
treatment was incubated with 10 μM FDA and 25 μM of
ethidium bromide and was visualized under fluorescent
microscope.
Superoxide dismutase activity
Superoxide dismutase activity was estimated as described
earlier [25]. In brief 2 x 106 cells were plated in 100 mm2
culture dishes and allowed to grow for 24 h. After 24 h of
CSC treatment, cells were washed, harvested and centri-
fuged at 200 x g for 10 min at 40C. Cell pellet was washed
with ice-chilled PBS and resuspended in PBS. Cells were
lysed by the three freeze-thaw cycles followed by sonic-
ation (Sonicator Q700, Qsonica) for 5 min in ice-chilled
water. After centrifugation at 800 x g for 10 min at 4 °C,
the supernatant was assayed for SOD.
PLA2 assay
The effect of CSC on the PLA2 activity was measured in
the presence/absence of PLA2-inhibitors by the modified
method of price [26]. In brief, samples were freshly
diluted in 2 mM HEPES at pH 7.5 and 20 μl of each
sample mixture, or buffer mixture as negative control
was put in the well of a round bottom 96 well micro plate.
180 μL of an assay mixture at pH 7.5 at 37 °C was added
to each sample. The plate was immediately read at
600 nm at one minute intervals for five minutes. Immedi-
ately after addition of substrate, the blue color of dye turns
yellow with pH change due to PLA2 activity and absorb-
ance decreases.
Reverse transcription-polymerase chain reaction (RT-PCR)
After treatment total RNA from both type of epithelial
cells was isolated using the method of Chomcznski et al
[27]. Analysis of mRNA levels of cPLA2 groups IVA,
IVB and IVC was done by RT-PCR. In PCR reactions
(25 μl) 100 ng cDNA was used as template DNA. The
primer sequences for the expression of all the genes
were taken from previously published literature [28].
The primer sequences used for this study are given in
(Additional file 1: Table S1).
Protein estimation
Protein content of cell lysate was measured in all sam-
ples by Bradford method [29]. Bovine Serum Albumin
(BSA) was used as a protein standard.
Statistical analysis
Values displayed in the results are mean ± standard devi-
ation of at least three independent experiments carried
out in triplicate. P < 0.05 was considered to be statically
significant. One way analysis of variance (ANOVA) and t
test were employed using SPSS software to govern statis-
tical significance of the results.
Results
Effect of CSC on cell viability and reactive oxygen species
in A549 and WI26 cells
In A549 cells, it was found that cell survival decreased
with increasing concentration of CSC from 1 μg/ml to
200 μg/ml and found to be 90.8 %, 84.2 %, 78.4 % and
76.4 % at 50 μg/ml, 100 μg/ml, 150 μg/ml and 200 μg/
ml concentrations respectively. Whereas in WI26 cells,
no significant change was observed in survival rate up to
100 μg/ml concentration of CSC. Moreover, it was
observed that at 150 μg/ml and 200 μg/ml concentra-
tions of CSC, survival rate of WI26 cells decreased to
95.7 % and 62.2 % (p < 0.05) respectively (Fig. 1).
Effects of CSC at various concentrations on ROS for-
mation in the two cell lines are shown in Fig. 2. It was
found that in A549 cells, even 1 μg CSC/ml increased
the formation of ROS to 3 fold, which was further
increased to 3.95 fold, 7.69 fold, 12.1 fold, 14.1 fold and
16.5 fold at 10 μg/ml, 50 μg/ml, 100 μg/ml, 150 μg/ml
and 200 μg/ml concentrations respectively (Fig. 2a). In
contrast to A549 cells, in WI26 cells CSC treatment
increased the ROS formation to 1.21 fold, 1.58 fold,
2.26 fold, 2.73 fold and 3.56 fold at 10 μg/ml, 50 μg/ml,
100 μg/ml, 150 μg/ml and 200 μg/ml concentrations
(Fig. 2b).
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Cells morphology
Since the morphology of two types of cells used in the
present study were highly affected (Additional file 1:
Figure S2) at higher concentrations (150 μg/ml and
200 μg/ml), these concentrations were not used in the next
part of the study. Among all other lower concentrations,
50 μg/ml and 100 μg/ml of CSC induced maximum ROS
production with optimum cell viability and hence were
preferred in most of the other experiments. Time period
was selected on the basis of our previous studies and pre-
liminary experiments at different time intervals using ROS
measurement and cell survival assay. 24 h time was found
to be optimum and was used for current study.
Effect of CSC on cellular integrity in A549 and WI26 cells
FDA uptake assay is an indicator of membrane integrity
and cytoplasmic esterase activity. Figure 3 is showing
the results of FDA and EtBr uptake in both types of cell
lines. There was maximum uptake of FDA with no cellu-
lar accumulation of EtBr at control levels in both the cell
lines. Accumulation of the fluorescein decreased and up-
take of the EtBr increased in a concentration dependent
manner in both the cell lines. Result obtained from the
assay indicted the membrane integrity was stable at 50
and 100 μg/ml of CSC treatment.
SOD levels in type I and type II epithelial cells
Effect of CSC treatment for 24 h on SOD in A549 and
WI26 cells is shown in the Fig. 4. It was found that SOD
activity was significantly higher in WI26 cells (0.278 IU/
μg protein) as compared to A549 (0.188 IU/μg protein)
cells. In the presence of 50 μg/ml of CSC concentration,
SOD activity increased significantly in WI26 and A549
cells by 1.68 and 1.49 fold respectively (p < 0.05).
CSC enhanced cPLA2 activity
Effect of CSC induced PLA2 activity in presence/absence
of PLA2 inhibitors is shown in Fig. 5. Working PLA2-
inhibitors concentration was decided on the basis of cell
viability, ROS and apoptosis experiments in the present
study (Data not shown). At basal level we observed very
low PLA2 activity in both type of lineages as optical
density (OD) decreased at every minute interval from
2.88 to 2.63, 2.44, 2.29 2.11 and 1.95 in A549 cells
(Fig. 5a), whereas from 3.13 to 2.95, 2.67, 2.49, 2.2 and
2.01 in WI26 cells. CSC at 50 μg/ml, significantly
induced PLA2 activity in both type of cells as OD de-
creased at every minute interval from 2.57 to 1.5, 0.98,
0.73, 0.59 and 0.52 in A549 cells whereas from 2.80 to
2.17, 1.22, 1.02, 0.88 and 0.75 in WI26 cells (p < 0.05)
(Fig. 5b). In presence of cPLA2 specific inhibitor ATK,
we observed low CSC-induced PLA2 activity when com-
pared to sPLA2 (YM26734) and iPLA2 (BEL) specific
inhibitors in both type of cells. In presence of cPLA2
and sPLA2 + iPLA2 inhibitor, the decrease in OD was
from 2.76 to 2.6, 2.41, 2.17, 1.88 and 1.6 (p < 0.05) and
from 2.66 to 1.74, 1.17, 0.9, 0.80 and 0.63 respectively in
A549 cells; whereas in WI26, OD decreased from 3.04
to 2.71, 2.47, 2.22, 1.93 and 1.70 (p < 0.05) and from 2.81
to 2.27, 1.61, 1.24, 1.02 and 0.94 respectively.
Fig. 1 Effect of CSC treatment on cell viability (MTT assay) in A-549 and
WI-26 cells. Both cell lines were treated with different concentrations of
CSC for 24 h. The results are expressed as mean ± SD of three different
experiments. *,#,p < 0.05. *CSC compared with A549 control. #CSC
compared with WI26 control. Concentrations of CSC were in μg/ml
Fig. 2 Effect of CSC treatment at different concentrations on ROS
production in lung epithelial type II (A-549) cells (a) and lung epithelial
type I (WI-26) cells (b), assayed by DCHF-DA fluorescent dye. The results
are expressed as mean ± SD of three separate experiments. *p < 0.05.
*CSC compared with their respective control
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CSC enhanced cPLA2s mRNA expression
Transcriptional modulations of various selected PLA2
groups (IVA, IVB and IVC) were studied at basal level
(Fig. 6a) and in presence of CSC as shown in Fig. 6b.
Densitometric analysis of all cPLA2 groups was done
(Table S2). In A549 cells, mRNA expression of all the
cPLA2 groups increased significantly in concentration
dependent manner in all CSC treated cells and the
most affected group was IVA (3.98 fold) followed by
IVC (2.97 fold) and IVB (1.62 fold) (p < 0.05). In WI26
cells also, CSC treatment showed significant increase in
mRNA expression of cPLA2 groups in a concentration
dependent manner and the most prominently induced
PLA2 group was IVA (1.95) followed by IVB (1.31) and
IVC (1.98) (p < 0.05).
Discussion
The lung is the only organ in the entire human archi-
tecture which has the greatest exposure to atmospheric
oxygen and other environmental toxicants such as
cigarette smoke [30, 31]. As we all knew that cigarette
smoke is a highly complex mixture having more than
5000 chemicals including high concentration of free
radicals and many of its components are known to be
carcinogens, co-carcinogens and mutagens [5]. Among
all type of cigarettes available in the Indian market, one of
the most commonly consumed includes Gold Flake (with
filter) [21] and same was used in the current study.
Cigarette smoke-induced chronic inflammation leads
to the destruction of alveolar septae, resulted to the loss
of elasticity and surface area for gas exchange, known as
emphysema [9] and rapidly induces production of ROS
thereby impairing endothelial functions [32]. The mech-
anisms leading to these changes after exposure of
cigarette smoke were not yet completely understood in
the two types of alveolar epithelial cells. However in-
creased level of free radicals/oxidants in epithelial cells
due to cigarette smoke leads to oxidative stress which is
considered to be one of the major factors responsible for
cell damage and death [31, 33, 34]. Using two lineages of
epithelial cell lines, we showed that exposure of CSC
leads to decrease in cell viability, increase in ROS pro-
duction, loosed membrane integrity and altered morph-
ology in a dose dependent manner at 24 h time period.
All these observed parameters are well known hallmarks
of inflammation and oxidative stress. Optimum time
period and different doses of CSC were already reported
by our group’s previously and same has been used in the
present study [20]. In the continuation of previous study,
we observed that CSC-induced ROS formation was found
to be increased in concentration dependent manner in
both WI26 (type I) cells as well as in A549 (type II) cells.
Fig. 3 Effect of CSC on cellular integrity in A-549 and WI-26 cells using FDA and EtBr uptake assay
Fig. 4 SOD activity after 50 μg/ml of CSC concentration at 24 h of
treatment in A549 and WI26 cells. The results are expressed as
mean ± SD of three separate experiments. *,#,αp < 0.05. *CSC
compared with their respective control, #A549 control compared
with WI26 control and αcompared with CSC threated WI26 cells
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However, the ROS formation was higher in A549 cells in
comparison of WI26 cells. One of the possible reasons of
such difference seems to be due to the difference in anti-
oxidant status in two types of cells. To find out the reason
behind, we investigated SOD levels in both type of cells
and the results obtained from the study clearly indicate
that WI26 cells had higher SOD activity in comparison of
A549 cells alone and in combination with CSC treatment,
its justify difference of ROS level finding among two types
of lineages. Our finding shows that type II (A549) cells are
Fig. 5 PLA2 activity at 50 μg/ml of CSC concentration alone or in combinations with PLA2 isoforms specific inhibitors at 24 h of treatment time in
A549 cells (a) and WI26 cells (b). The decrease in absorbance is directly proportional to PLA2 activity. The results are expressed as mean ± SD of
three separate experiments. *,#p < 0.05. *CSC 50 μg/ml activity response compared with their respective control at every minutes interval. #CSC
50 μg/ml in combination with cPLA2 specific inhibitor (ATK) activity response compared with their respective CSC 50 μg/ml alone at every
minutes interval
Fig. 6 mRNA expression of different cPLA2 groups at constitutive level (a) and in presence of different concentrations of CSC (b) in A549 and WI26
cells. β-actin was used as an internal control for normalization of mRNA levels of cPLA2 groups
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comparatively more sensitive than type I (WI26) cells in
terms of cell viability, higher ROS production as well as
lower SOD levels. Moreover, type-I cells are highly ex-
posed to airway insults and have been described as ter-
minally differentiated cells, suggesting that they are
incapable of cell division and cannot change their pheno-
typic expression. On the other hand, type-II epithelial cells
are considered as progenitor cells which proliferate to re-
epithelialize the damaged alveolar surfaces and then they
transforms into the type-I epithelial cells. In these distinct-
ive circumstances, type-II epithelial cells may be consid-
ered to show characteristics of stem cells mechanisms in
alveolar repair [35–37] and seems to be very sensitive in
contrast to type-I epithelial cells as we observed in the
present study.
PLA2s are the important molecules involved in the
remodeling of the membrane lipids and also in modula-
tion of cell signaling which contributes to either the pro-
motion or the resolution of inflammation during various
lung pathologies [38, 39]. Moreover PLA2 activity in
cancer tissues found to be much higher than normal
cells [40]. In this direction, we examined the PLA2 activ-
ity in both type of lineages. In our observations, we
found increased PLA2 activity after exposure of CSC.
Our results are in correlation with another recently de-
scribed study in which increased PLA2 activity has been
reported after cigarette smoke exposure [41]. PLA2s have
various isoforms but cPLA2s seems to play crucial role
in CSC-induced inflammatory conditions. Results ob-
tained from the present study indicated maximum de-
crease in cPLA2s activity in both type of cells by using
commercially available isoform specific PLA2 inhibi-
tor(s). It is well documented that cPLA2s have key regu-
latory roles in the invasive migration, proliferation, and
capillary-like tubule formation of vascular endothelial
cells as well as in tumor angiogenesis in lung cancer
(mouse models) [42]. Our study is well supported by an-
other recent research in which involvement of cPLA2
has been reported in asthmatic and COPD cases [43].
Moreover, several cPLA2 isoform specific inhibitors are
commercially available and are in clinical trials for vari-
ous inflammatory diseases and has been discussed in the
review by Victoria [44]. The results of CSC simulated
lung epithelial cell lineage treated with cPLA2 specific
inhibitor such as ATK may also support the role of
cPLA2 in lung pathologies.
Furthermore, to find out the role of specific cPLA2, we
also characterized the comparative transcriptional level
expression of cPLA2s at constitutive level and it was ob-
served that all cPLA2s expressed in human lung epithe-
lial type I (WI26) and type II (A549) cells. In presence of
cigarette smoke condensate there was an increase in all
cPLA2 groups but most predominantly induced group
was PLA2 IVA in two different lineages of cells. In best
of our knowledge, we are first group to report maximum
expression of PLA2 IVA among all cPLA2s. The involve-
ment of PLA2 IVA is already documented in several
diseases and it has been used as a target molecule [45].
In this context, targeting group IVA may built-up new
prospects in CSC-induced lung pathologies.
CSC-induced difference in the expression level of cPLA2s
seems to play crucial role during lung pathologies. In this
prospective, we also observed that CSC-induced cPLA2s
expression and ROS levels were comparatively higher in
A549 cells when compared to WI26 cells. Our finding
clearly advocates that CSC-induced expression level of
cPLA2 group’s seemed to be dependent on ROS levels gen-
erated. Our observation is supported by another study
which suggested that cigarette smoke activates cPLA2-
expression through NADPH oxidase/ROS in human tra-
cheal smooth muscle cells [8].
The role of specific cPLA2s in cigarette smoking in-
duced lung pathologies remains elusive due to combine
effect of cigarette smoke constituents, smaller to larger
extent expression of all isoforms and distinct functions
attributable to each isoform. Still PLA2 IVA had max-
imum expression in both lineages and can be of max-
imum interest in CSC induced inflammatory diseases.
Now a days combine strategies are required to deal with
such inflammatory situations. Firstly, dietary intake of
biological molecules which are rich source of antioxi-
dants and have anti-inflammatory effects [46]. Secondly,
along with healthy diet use of cPLA2s specific analogs
especially for PLA2 IVA may be a novel effective therapy
in cigarette smoke related lung pathologies.
Conclusion
In conclusion, it is worth mentioning; here the present
study indicates involvement of specific cPLA2 IVA as a
potential biomolecule candidate during cigarette smoke
induced oxidative stress in type I and type II alveolar
epithelial cells and strategies to target them may be key
approach in cigarette smoke induced lung pathologies.
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Additional file 1: Supplementary data. Table S1. Primer Sequences of
various genes. Table S2. CSC-induced mRNA expression of various cPLA2
groups in A-549 and WI-26 Cells. The values (mean ± SD of three different
experiments) are in folds of control values. Figure S1. Schematic presentation
of proposed plan of experimental design. Figure S2. Effect of CSC treatment
at concentrations’ of 150 μg/ml (b) and 200 μg/ml (c) on cell morphology in
lung epithelial type II (A-549) cells and type I (WI-26) cells. Figure 2a
shows the normal morphology in two types of the cells (Magnification 5x).
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